JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Financials | 11.13% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Babcock & Wilcox
BW
$1.53B
| $132K | ﹤0.01% |
20,535
-33,181
| -62% | -$232K |
|
5227
Home Bancorp
HBCP
$566M
| $132K | ﹤0.01% |
3,414
-906
| -21% | -$33.7K |
|
5228
iShares Core US REIT ETF
USRT
$4.64B
| $132K | ﹤0.01% |
2,252
+597
| +36% | +$36.3K |
|
5229
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$541M
| $131K | ﹤0.01% |
2,550
-8,836
| -78% | -$477K |
|
|
ELAT
5230
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $131K | ﹤0.01% |
+2,626
| New | +$137K |
|
|
TPGS
5231
DELISTED
TPG Pace Solutions Corp.
TPGS
| $131K | ﹤0.01% |
+13,000
| New | +$130K |
|
5232
Cardiff Oncology
CRDF
$74.9M
| $130K | ﹤0.01% |
19,456
+1,378
| +8% | +$8.66K |
|
|
GOOS
5233
Canada Goose Holdings
GOOS
$854M
| $130K | ﹤0.01% |
3,639
| – | – |
|
5234
IonQ
IONQ
$18.7B
| $130K | ﹤0.01% |
+12,500
| New | +$127K |
|
|
CAMP
5235
DELISTED
CalAmp Corp.
CAMP
| $130K | ﹤0.01% |
569
-24
| -4% | -$6.35K |
|
5236
BayCom
BCML
$339M
| $129K | ﹤0.01% |
6,940
-8,356
| -55% | -$150K |
|
5237
Harvard Bioscience
HBIO
$30.3M
| $129K | ﹤0.01% |
1,847
-3,009
| -62% | -$239K |
|
|
IAS
5238
DELISTED
Integral Ad Science
IAS
| $129K | ﹤0.01% |
6,254
-93,746
| -94% | -$1.85M |
|
5239
Global X SuperDividend ETF
SDIV
$1.21B
| $129K | ﹤0.01% |
3,252
-1,356
| -29% | -$54.7K |
|
5240
Universal Logistics Holdings
ULH
$509M
| $129K | ﹤0.01% |
6,418
-4,952
| -44% | -$107K |
|
5241
Gyre Therapeutics
GYRE
$708M
| $128K | ﹤0.01% |
4,148
-7,185
| -63% | -$236K |
|
|
VINC
5242
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $128K | ﹤0.01% |
396
+44
| +13% | +$12.8K |
|
|
SURF
5243
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $128K | ﹤0.01% |
16,873
+1,673
| +11% | +$10.7K |
|
|
CFMS
5244
DELISTED
Conformis, Inc. Common Stock
CFMS
| $128K | ﹤0.01% |
3,858
+3,102
| +410% | +$109K |
|
5245
Cyclerion Therapeutics
CYCN
$17.7M
| $127K | ﹤0.01% |
2,067
-922
| -31% | -$60.3K |
|
5246
Direxion Daily Financial Bull 3x ETF
FAS
$2.49B
| $127K | ﹤0.01% |
1,101
-238
| -18% | -$27.3K |
|
5247
IRIDEX
IRIX
$14.9M
| $127K | ﹤0.01% |
16,535
-2,632
| -14% | -$18.5K |
|
|
LITS
5248
Lite Strategy Inc
LITS
$30.2M
| $127K | ﹤0.01% |
2,301
-2,643
| -53% | -$145K |
|
|
SIEN
5249
DELISTED
Sientra, Inc.
SIEN
| $127K | ﹤0.01% |
2,220
-3,599
| -62% | -$246K |
|
5250
CorMedix
CRMD
$592M
| $126K | ﹤0.01% |
27,084
-23,359
| -46% | -$136K |
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $27.4B in Q3 2021, closing 499 positions and reducing 3,086 holdings. Its most notable exit was Weingarten Realty Investors, an estimated $401M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Toast worth $138M.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 499 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.